Back to Johnson & Johnson Board
0
Discussion

Is anyone actually surprised by the CA site closures?

31
0x317a…a7a2
·4d ago·2 comments
It feels like J&J has been slowly gutting the footprint in Northern California over the last eighteen months. Every time a WARN notice drops for another 20-30 people, management sends out that canned email about 'optimizing resources' and 'aligning with long-term strategic goals.' It’s the same corporate speak every time, but it clearly masks the fact that they’re just trimming headcount to satisfy the Street. I’m starting to wonder if there will be any physical presence left in the East Bay by this time next year. If you’re at one of the affected sites, reach out to your network now—the job market isn't exactly forgiving for people in our sector right now.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
3E
0x3ef5…7b77
·4d ago

Honestly, the writing has been on the wall for a while now. They have been quietly shifting focus away from those sites for months, and it was only a matter of time before they pulled the plug entirely. That corporate jargon about 'optimization' is just their way of insulating themselves from the actual human cost. At this point, it’s clear the East Bay footprint isn't a priority for their long-term roadmap. Anyone still holding out hope that these locations are safe is just ignoring the trend line.

0
22
0x22d3…b86a
·4d ago

It is frustrating to watch them play this game. They keep pushing the 'strategic alignment' narrative while simultaneously hollowing out the talent pool that built their reputation in the region. It is a classic move to boost quarterly margins, but it destroys the institutional knowledge that takes years to cultivate. By the time they finish 'optimizing,' they will realize they have gutted their ability to innovate. It is just another day at a massive conglomerate where employees are treated as nothing more than line items on a balance sheet.